Spots going fast for free YMCA Diabetes Prevention Program starting May 1

Enroll by April 24 for the 12-month lifestyle program

The next cohort will launch on May 1, and will meet on Wednesdays from 12-1 p.m. in University Hall on the Medical Campus.  Only eight spots remain.

Check out the success stories and positive impacts participants and fellow colleagues have shared.

Interested in Enrolling?

Complete details are available on the Diabetes Resources and Services page, such as the qualifications, program guidelines, and the full 12 month schedule.

To enroll, please contact Janella Straw with the YMCA at 513-362-2051 or jstraw@myy.org by April 24.  Only eight spots are remaining, so save your spot today.

Eligible employees must meet the qualifications below:

  • Enrolled in the UC Anthem medical plan for duration of DPP,
  • At least 18 years old,
  • Have a BMI ≥25, and
  • Prediabetes confirmed via one of three blood tests or previous diagnosis of gestational diabetes within six months of the date the DPP program begins and by May 1.

Additional Features and Privacy:

  • The DPP is being offered as a pilot for up to 100 eligible employees. 
  • No cost ($429 value) for eligible and enrolled participants.
  • FREE individual yearlong YMCA membership ($750 value), and 20 Be Well UC points ($20 value) for completing all 25 sessions.
  • No personal health information will be shared with UC.  Only names and M#s of participants will be shared with UC to confirm eligibility.

Questions?

Reach out to the Be Well UC, your employee wellness program, at wellness@uc.edu or 513-556-0116.

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.